FDA Adverse Event Injury Summary report: N

APEX MONORAIL

MDR report key: 2041950 · Received April 6, 2011

Report

Report Number
2134265-2011-01326
Event Type
Injury
Date Received
April 6, 2011
Date of Event
January 10, 2011
Report Date
March 9, 2011
Manufacturer
BOSTON SCIENTIFIC - GALWAY
Product Code
LOX
PMA / PMN Number
P860019
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
ES
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DEVICE EVALUATED BY MANUFACTURER: AS THE UNIT HAS NOT BEEN RETURNED, A TECHNICAL ANALYSIS COULD NOT BE PERFORMED. THE MANUFACTURING RECORDS WERE REVIEWED AND NO ISSUES OR DISCREPANCIES WERE FOUND AND MET ALL SPECIFICATIONS. THE MOST PROBABLE ROOT CAUSE IS LISTED AS CAUSED BY OTHER DEVICE. (B)(4).

Description of Event or Problem · 1

(B)(4) STUDY. SAME CASE AS MFR REPORT #: 2134265-2011-01325. IT WAS REPORTED THAT DURING A STENTING TREATMENT PROCEDURE, A VESSEL PERFORATION OCCURRED. THE INDEX PROCEDURE TREATED THE 80% STENOSED, 2.5X14MM TARGET LESION LOCATED IN THE MID LEFT ANTERIOR DESCENDING (LAD) ARTERY. TREATMENT CONSISTED OF PRE-DILATION USING TWO 2.0X15MM APEX BALLOONS AND THE PLACEMENT OF A (B)(4) STUDY STENT. A PERFORATION OF THE LAD WITH BLOOD EFFUSION WAS NOTED AFTER THE DEPLOYMENT OF THE STUDY STENT WHICH WAS TREATED WITH AN ADDITIONAL (B)(4) STUDY STENT AND A NON BSC GRAFTING STENT. THE EVENT WAS CONSIDERED RESOLVED THE SAME DAY. IN ADDITION, A NON-TARGET LESION LOCATED IN THE 1ST OBTUSE MARGINAL BRANCH WAS ALSO TREATED AT THE INDEX PROCEDURE WHICH WAS TREATED WITH A 2.5X12MM PROMUS ELEMENT. THE PATIENT WAS DISCHARGED 3 DAYS POST THE INDEX PROCEDURE ON ASPIRIN AND CLOPIDOGREL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 APEX MONORAIL CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS LOX BOSTON SCIENTIFIC - GALWAY H7493895915200 13937391

Patients

Seq Age Sex Outcome Treatment
1 73 YR Required Intervention (B)(4) STUDY STENT| 2.0X15MM APEX BALLOON